• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Going Beyond Topical Steroids and Calcineurin Inhibitors for AD Treatment

Opinion
Video

The panel examines the evolution of atopic dermatitis (AD) treatment beyond topical steroids and calcineurin inhibitors, while evaluating the safety and efficacy of a specific topical therapy in AD management.

Related Videos
4 experts in this video
4 experts in this video
Dr James Chalmers
Dr Julia Rotow
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.